Skip to main content
Clinical Trials/NCT00777621
NCT00777621
Completed
Not Applicable

Caloric Restriction, Exercise, and Glucoregulation in Humans

St. Louis University1 site in 1 country69 target enrollmentApril 2008
ConditionsDiabetes

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Diabetes
Sponsor
St. Louis University
Enrollment
69
Locations
1
Primary Endpoint
Glucoregulatory function
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

Weight loss induced by caloric restriction alone (CR) and by exercise alone (EX) result in similar effects on blood glucose and insulin. The purpose of this study is to assess the hypothesis that weight loss through caloric restriction plus exercise will result in greater improvements on glucose tolerance and insulin action than similar weight losses through CR or EX alone.

Detailed Description

Participants are randomized into caloric restriction, exercise, and caloric restriction plus exercise weight loss groups. Measurements of blood glucose and insulin, oral glucose tolerance, and matched glucose infusion will be done at baseline and after weight loss of 6% of body weight. Other tests include maximal oxygen uptake (VO2max), strength tests, blood pressure, blood lipids, serum inflammatory markers, dual X-ray absorptiometry (DEXA) for bone density and body composition, physical activity levels, dietary intakes, and measures of arterial stiffness.

Registry
clinicaltrials.gov
Start Date
April 2008
End Date
March 2015
Last Updated
10 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Edward Weiss, Ph.D.

Associate Professor

St. Louis University

Eligibility Criteria

Inclusion Criteria

  • females postmenopausal
  • no diabetes, cardiovascular disease, cancer
  • no orthopedic problems
  • not currently exercising
  • BMI between 25 and 29.9
  • nonsmokers

Exclusion Criteria

  • current regular exercisers
  • premenopausal women
  • cardiovascular disease, lung disease, cancer, diabetes

Outcomes

Primary Outcomes

Glucoregulatory function

Time Frame: 3-4 months

Study Sites (1)

Loading locations...

Similar Trials